{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:15:46Z","timestamp":1767989746315,"version":"3.49.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Skin cancer generally causes disproportionate morbidity and mortality in people of colour. Although skin cancers occur most frequently in White individuals overall, cutaneous T-cell lymphoma (CTCL) is an exception. CTCL is a rare skin cancer comprising several subtypes of non-Hodgkin lymphoma; each contains a unique clinical profile that varies with race. Our aim is to review and compile the differences in epidemiology, clinical presentation, treatments and outcomes of the CTCL subtypes in Black, Asian or Pacific Islander (API) and Hispanic patients. The current literature supports that there are nuances in the course of CTCL that differ with race. Across multiple studies, racial differences in incidence patterns have been reported, with the highest rates among Black patients. Cutaneous manifestations of CTCL are highly variable in people of colour, and the predilection for clinical CTCL variants often differs with race, as well as severity of cutaneous involvement (body surface area). Response to and type of treatment also differs among people of colour and may be partially attributable to the varying CTCL subtypes experienced by certain races. Prognostic factors tend to vary with race, although Black patients consistently experience poor outcomes, while API patients may have a more favourable prognosis. Currently, there is no definitive conclusion to account for differences observed in patients with skin of colour with CTCL; however, biological and socioeconomic factors have been proposed as potential drivers. As the proportion of people of colour in our population continues to grow, adequate physician awareness and knowledge of racial nuances in CTCL are necessary to begin addressing these disparities.<\/jats:p>","DOI":"10.1093\/ced\/llae338","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:26:05Z","timestamp":1724459165000},"page":"279-286","source":"Crossref","is-referenced-by-count":3,"title":["Cutaneous T-cell lymphoma in skin of colour: a review"],"prefix":"10.1093","volume":"50","author":[{"given":"Daniel","family":"Mosallaei","sequence":"first","affiliation":[{"name":"University of Southern California, Department of Dermatology , Los Angeles, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9229-343X","authenticated-orcid":false,"given":"Sierra I","family":"Thomas","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Nebraska Medical Center, Department of Dermatology , Omaha, NE ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Lobl","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center , Pittsburgh, PA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shauna","family":"Higgins","sequence":"additional","affiliation":[{"name":"University of Southern California, Department of Dermatology , Los Angeles, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica B","family":"Lee","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Department of Dermatology , Omaha, NE ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Stephany","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Department of Dermatology , Omaha, NE ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Wysong","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Department of Dermatology , Omaha, NE ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"2025012715573864400_llae338-B1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jaad.2005.08.063","article-title":"Skin cancer in skin of color","volume":"55","author":"Gloster","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2014.10.019","article-title":"Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and S\u00e9zary syndrome in the southeastern United States: a single-\u00adinstitution cohort","volume":"72","author":"Desai","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2025012715573864400_llae338-B4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973\u20132002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"2025012715573864400_llae338-B5","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"2025012715573864400_llae338-B6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/10428194.2012.729831","article-title":"Incidence and survival patterns of cutaneous T-cell lymphomas in the United States","volume":"54","author":"Imam","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2025012715573864400_llae338-B7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12185-021-03179-7","article-title":"Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia","volume":"114","author":"Lee","year":"2021","journal-title":"Int J Hematol"},{"key":"2025012715573864400_llae338-B8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma","volume":"12","author":"Wilson","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025012715573864400_llae338-B9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaad.2008.09.063","article-title":"Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides","volume":"60","author":"Sun","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/cam4.472","article-title":"Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries","volume":"4","author":"Litvinov","year":"2015","journal-title":"Cancer Med"},{"key":"2025012715573864400_llae338-B11","doi-asserted-by":"publisher","first-page":"205.e1","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): Part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jnma.2019.08.006","article-title":"Racial disparities in the clinical presentation and prognosis of patients with mycosis fungoides","volume":"111","author":"Huang","year":"2019","journal-title":"J Natl Med Assoc"},{"key":"2025012715573864400_llae338-B13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaad.2008.10.031","article-title":"Cutaneous T-cell lymphoma in skin of color","volume":"60","author":"Hinds","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/cup.12217","article-title":"Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study","volume":"40","author":"Castano","year":"2013","journal-title":"J Cutan Pathol"},{"key":"2025012715573864400_llae338-B15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jaad.2014.07.049","article-title":"Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients","volume":"71","author":"Boulos","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1525-1470.2000.017005352.x","article-title":"Profile and outcome of childhood mycosis fungoides in Singapore","volume":"17","author":"Tan","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"2025012715573864400_llae338-B17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2006.00290.x","article-title":"Retrospective 5-year review of 131 patients with mycosis fungoides and S\u00e9zary syndrome seen at the National Skin Centre, Singapore","volume":"47","author":"Tan","year":"2006","journal-title":"Australas J Dermatol"},{"key":"2025012715573864400_llae338-B18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1365-4632.2010.04567.x","article-title":"Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991\u20132006","volume":"49","author":"Alsaleh","year":"2010","journal-title":"Int J Dermatol"},{"key":"2025012715573864400_llae338-B19","doi-asserted-by":"publisher","first-page":"575120","DOI":"10.5402\/2012\/575120","article-title":"Cutaneous T-cell lymphoma in Asians","volume":"2012","author":"Jang","year":"2012","journal-title":"ISRN Dermatol"},{"key":"2025012715573864400_llae338-B20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jaad.2021.06.860","article-title":"Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: a 29-year review","volume":"86","author":"Suh","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1525-1470.2010.01129.x","article-title":"Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait","volume":"27","author":"Nanda","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"2025012715573864400_llae338-B22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2133.2000.03307.x","article-title":"Pityriasis lichenoides-like mycosis fungoides in children","volume":"142","author":"Ko","year":"2000","journal-title":"Br J Dermatol"},{"key":"2025012715573864400_llae338-B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2133.2009.09109.x","article-title":"Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas","volume":"161","author":"Morizane","year":"2009","journal-title":"Br J Dermatol"},{"key":"2025012715573864400_llae338-B24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jaad.2003.10.003","article-title":"Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma","volume":"50","author":"Hodak","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000051829","article-title":"Ichthyosiform mycosis fungoides","volume":"204","author":"Marzano","year":"2002","journal-title":"Dermatology"},{"key":"2025012715573864400_llae338-B26","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"2025012715573864400_llae338-B27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.073","article-title":"Outcomes and prognostic factors in African American and Black patients with mycosis fungoides\/S\u00e9zary syndrome: retrospective analysis of 157 patients from a referral cancer center","volume":"83","author":"Geller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: an analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jaad.2012.11.021","article-title":"Racial differences in mycosis fungoides: a retrospective study with a focus on eosinophilia","volume":"68","author":"Zampella","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clml.2013.12.018","article-title":"Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008","volume":"14","author":"Nath","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025012715573864400_llae338-B31","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025012715573864400_llae338-B32","doi-asserted-by":"crossref","first-page":"AB182","DOI":"10.1016\/j.jaad.2016.02.717","article-title":"Racial differences in survival of patients with Sezary syndrome in the United States: a population-based study of 204 cases","volume":"74","author":"[No authors listed]","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B33","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/bjh.15222","article-title":"Ethnic disparity in primary cutaneous CD30+ T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer Database","volume":"181","author":"Su","year":"2018","journal-title":"Br J Haematol"},{"key":"2025012715573864400_llae338-B34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2105\/AJPH.89.8.1240","article-title":"Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality","volume":"89","author":"Weinstock","year":"1999","journal-title":"Am J Public Health"},{"key":"2025012715573864400_llae338-B35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2014.05.005","article-title":"Early-onset mycosis fungoides among African American women: a single-institution study","volume":"71","author":"Balagula","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/pde.13226","article-title":"Clinical outcome and prognosis of young patients with mycosis fungoides","volume":"34","author":"Virmani","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"2025012715573864400_llae338-B37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jamadermatol.2013.7747","article-title":"Outcomes after diagnosis of mycosis fungoides and S\u00e9zary syndrome before 30\u2005years of age: a population-based study","volume":"150","author":"Ai","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2025012715573864400_llae338-B38","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"},{"key":"2025012715573864400_llae338-B39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2017.05.015","article-title":"CD8+ mycosis fungoides: a low-grade lymphoproliferative disorder","volume":"77","author":"Martinez-Escala","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0190-9622(00)90006-9","article-title":"Hypopigmented mycosis fungoides: treatment and a 6(1\/2)-year follow-up of 9 patients","volume":"42","author":"Akaraphanth","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ced.12364","article-title":"Narrow-band ultraviolet B phototherapy for mycosis fungoides in children","volume":"39","author":"Koh","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"2025012715573864400_llae338-B42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2230.2011.04197.x","article-title":"Efficacy of narrowband ultraviolet B twice weekly for hypopigmented mycosis fungoides in Asians","volume":"37","author":"Kanokrungsee","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"2025012715573864400_llae338-B43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/09546634.2014.946381","article-title":"Racial differences in the use of extracorporeal photopheresis for mycosis fungoides","volume":"26","author":"Agi","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"2025012715573864400_llae338-B44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/COC.0b013e31825494d3","article-title":"Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex","volume":"36","author":"Hinds","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"2025012715573864400_llae338-B45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21873\/anticanres.13105","article-title":"Cutaneous T-cell lymphoma: trends in radiation doses and patterns of care 2004\u20132015","volume":"39","author":"Miccio","year":"2019","journal-title":"Anticancer Res"},{"key":"2025012715573864400_llae338-B46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D30GM267V6","article-title":"Mycosis fungoides stage IB progressing to cutaneous tumors","volume":"17","author":"Berger","year":"2011","journal-title":"Dermatol Online J"},{"key":"2025012715573864400_llae338-B47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5070\/D34ZD5429J","article-title":"Mycosis fungoides with depigmentation secondary to treatment","volume":"13","author":"Firoz","year":"2007","journal-title":"Dermatol Online J"},{"key":"2025012715573864400_llae338-B48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02850354","article-title":"Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report","volume":"23","author":"Tomasiewicz","year":"2006","journal-title":"Adv Ther"},{"key":"2025012715573864400_llae338-B49","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1080\/10428194.2021.1888376","article-title":"Clinical characteristics and outcomes of Black patients with mycosis fungoides and S\u00e9zary syndrome: a subgroup analysis of the phase III MAVORIC trial","volume":"62","author":"Johnson","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"2025012715573864400_llae338-B50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jaad.2022.10.029","article-title":"Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients","volume":"88","author":"Hooper","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B51","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.jaad.2023.08.106","article-title":"Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: a population study of the US SEER registry","volume":"90","author":"Wu","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2025012715573864400_llae338-B52","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1080\/10428194.2020.1779259","article-title":"Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)","volume":"61","author":"Allen","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2025012715573864400_llae338-B53","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1080\/10428194.2022.2067999","article-title":"African American and Caucasian patients with S\u00e9zary syndrome have no differences in outcomes at an ethnically diverse urban medical center","volume":"63","author":"Martini","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"2025012715573864400_llae338-B54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clml.2023.05.001","article-title":"Characterizing outcomes in visceral cutaneous T-cell lymphoma: a single center retrospective study","volume":"23","author":"Zhuang","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025012715573864400_llae338-B55","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.3390\/ijerph20043578","article-title":"Disparities in cutaneous T-cell lymphoma incidence by race\/ethnicity and area-based socioeconomic status","volume":"20","author":"Wiese","year":"2023","journal-title":"Int J Environ Res Public Health"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae338\/60481757\/llae338.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae338\/60481757\/llae338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae338\/60481757\/llae338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T15:58:16Z","timestamp":1737993496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/2\/279\/7740020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8,23]]},"published-print":{"date-parts":[[2025,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae338","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,8,23]]}}}